脑放射性毒性相关15CAcBRT基因表达特征预测胶质母细胞瘤患者生存预后
本研究采用多组学方法,通过分析放射性脑毒性相关单核苷酸变异鉴定放射毒性相关基因(RGs),建立蛋白互作网络,并在胶质母细胞瘤生物发现门户数据库和中国胶质瘤基因组图谱数据集中评估RGs及其功能组对胶质母细胞瘤预后的影响。研究识别出具有预后价值的15CAcBRT分子特征,其外部验证证实临床相关性独立于年龄、MGMT启动子甲基化状态和IDH突变状态。IL6、APOE和MAOB基因表达水平显著改变,可用于药物重定位;15CAcBRT相关生物网络涉及癌症和神经退行性疾病通路,3D结构分析揭示神经肿瘤学潜在新治疗靶点。
要点
- 15CAcBRT是放射性脑毒性相关分子特征,对胶质母细胞瘤患者具有预后意义。
- 15CAcBRT外部验证证实其临床相关性独立于年龄、MGMT启动子甲基化和IDH突变状态。
- IL6、APOE和MAOB基因表达水平显著改变,可用于药物重定位。
核心结论
- 15CAcBRT是放射性脑毒性相关分子特征,对胶质母细胞瘤患者具有预后意义,并可作为药物重定位和开发新疗法的枢纽。
研究设计与样本
- 通过分析放射性脑毒性相关单核苷酸变异鉴定放射毒性相关基因,利用蛋白互作网络建立功能关系,在胶质母细胞瘤生物发现门户数据库临床样本中评估预后影响,并在中国胶质瘤基因组图谱数据集中进行外部验证,采用计算3D结构分析识别放射毒性和推定致病变异簇。
主要发现
- 通过分析COMT和APOE蛋白功能组,识别出具有胶质母细胞瘤预后价值的放射性脑毒性相关15CAcBRT分子特征。
- 15CAcBRT的外部验证证实其临床相关性独立于年龄、MGMT启动子甲基化状态和IDH突变状态。
- IL6、APOE和MAOB基因表达水平显著改变,可用于药物重定位。
- 与15CAcBRT特征相关的生物网络涉及癌症和神经退行性疾病相关通路。
- 放射毒性相关基因编码蛋白中放射毒性和推定致病变异的3D簇分析揭示了神经肿瘤学潜在新治疗靶点。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Glioblastoma is the most common and devastating primary brain cancer. Radiotherapy is standard of care; however, it is associated with brain radiation toxicity (BRT). This study used a multi-omics approach to determine whether BRT-related genes (RGs) harbor survival prognostic value and whether their encoded proteins represent novel therapeutic targets for glioblastoma. METHODS: RGs were identified through analysis of single-nucleotide variants associated with BRT (R-SNVs). Functional relationships between RGs were established using Protein-Protein Interaction networks. The influence of RGs and their functional groups on glioblastoma prognosis was evaluated using clinical samples from the Glioblastoma Bio-Discovery Portal database and validated using the Chinese Glioma Genome Atlas dataset. The identification of clusters of radiotoxic and putative pathogenic variants in proteins encoded by RGs was achieved by computational 3D structural analysis. RESULTS: We identified the BRT-related 15CAcBRT molecular signature with prognostic value in glioblastoma, by analysis of the COMT and APOE protein functional groups. Its external validation confirmed clinical relevance independent of age, MGMT promoter methylation status, and IDH mutation status. Interestingly, the genes IL6, APOE, and MAOB documented significant gene expression levels alteration, useful for drug repositioning. Biological networks associated with 15CAcBRT signature involved pathways relevant to cancer and neurodegenerative diseases. Analysis of 3D clusters of radiotoxic and putative pathogenic variants in proteins coded by RGs unveiled potential novel therapeutic targets in neuro-oncology. CONCLUSIONS: 15CAcBRT is a BRT-related molecular signature with prognostic significance for glioblastoma patients and represents a hub for drug repositioning and development of novel therapies.
引用
- Reyes-González J, Barajas-Olmos F, García-Ortiz H, et al. Brain radiotoxicity-related 15CAcBRT gene expression signature predicts survival prognosis of glioblastoma patients. Neuro Oncol. 2023. PMID: 35802478. doi:10.1093/neuonc/noac171
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。